Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Saturday, July 11 2009 1:52pm ET - U.S. Markets Closed.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > Alliance Pharmaceutical Corp. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Alliance Pharmaceutical Corp. Company Profile
Watch out red blood cells -- Alliance Pharmaceutical may be taking over your job. The firm is developing a chemical emulsion called Oxygent for use as a temporary oxygen carrier in surgery patients. Oxygent delivers oxygen to vital organs to prevent tissue damage or organ failure during surgery. The company is also developing Oxygent as a therapy to protect gastrointestinal organs. (Often the body will conserve blood for the heart and brain and deprive the intestines of blood during surgery.) In addition, Oxygent could reduce the need for blood transfusions during surgery. Alliance Pharmaceutical is working with LEO Pharma to get Oxygent approved in the European Union and Canada.
Headlines for Alliance Pharmaceutical Corp.
ALLIANCE PHARMACEUTICAL CORP. Financials
EDGAR Online Financials - Tue Jun 2
ALLIANCE PHARMACEUTICAL CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Fri May 15
ALLIANCE PHARMACEUTICAL CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Tue Feb 17
ALLIANCE PHARMACEUTICAL CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online - Fri Nov 14
More Headlines...
More on Alliance Pharmaceutical Corp.
Quote Research
Chart SEC
News Insider
Profile Financials
Reports    
Contact Information
Address: 7590 Fay Ave., Ste. 402
La Jolla, CA 92037
Phone:858-410-5200
Fax:858-410-5201
Financial Highlights
Fiscal Year End:June
Revenue (2008):0.10 M
Revenue Growth (1 yr):(-81.50%)
Employees (2008):3
Employee Growth (1 yr):(-25.00%)
Key People
Chairman and CEO: Duane J. Roth
President and COO: B. Jack DeFranco
Industry Information
Sector: Healthcare
Industry: Diagnostic Substances
Top Competitors
Biopure Corporation (bpur)
ImaRx Therapeutics, Inc. (imrx.ob)
Northfield Laboratories Inc. (nfldq.pk)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?